IL32 and type 2 diabetes mellitus: To a lesser extent, patients with autoimmune diseases, including psoriasis, granulomatosis with polyangiitis, myasthenia graves, and type 2 diabetes, have also demonstrated a higher serum level of IL-32 than healthy controls (32–34).